The inhibitory effects of PGG and EGCG against the SARS-CoV-2 3C-like protease
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The inhibitory effects of PGG and EGCG against the SARS-CoV-2 3C-like protease
Authors
Keywords
3CL protease (3CLpro), COVID-19, EGCG, PGG, SARS-CoV-2
Journal
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-01-07
DOI
10.1016/j.bbrc.2020.12.106
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China
- (2020) Qiurong Ruan et al. INTENSIVE CARE MEDICINE
- Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicines
- (2020) Xin Liu et al. Journal of Genetics and Genomics
- Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
- (2020) Guangdi Li et al. NATURE REVIEWS DRUG DISCOVERY
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients
- (2020) Lirong Zou et al. NEW ENGLAND JOURNAL OF MEDICINE
- Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
- (2020) Canrong Wu et al. Acta Pharmaceutica Sinica B
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- COVID-19: consider cytokine storm syndromes and immunosuppression
- (2020) Puja Mehta et al. LANCET
- Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
- (2020) Zhenming Jin et al. NATURE
- Natural products and their derivatives against coronavirus: A review of the non‐clinical and pre‐clinical data
- (2020) Muhammad T. Islam et al. PHYTOTHERAPY RESEARCH
- Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review
- (2020) Sasmita Poudel Adhikari et al. Infectious Diseases of Poverty
- Tea Polyphenols EGCG and Theaflavin Inhibit the Activity of SARS-CoV-2 3CL-Protease In Vitro
- (2020) Minsu Jang et al. Evidence-based Complementary and Alternative Medicine
- Computational screening of medicinal plant phytochemicals to discover potent pan-serotype inhibitors against dengue virus
- (2019) Muhammad Tahir ul Qamar et al. Scientific Reports
- Delayed intervention with a novel SGLT2 inhibitor NGI001 suppresses diet‐induced metabolic dysfunction and nonalcoholic fatty liver disease in mice
- (2019) Hao Chiang et al. BRITISH JOURNAL OF PHARMACOLOGY
- Inhibition of SARS-CoV 3CL protease by flavonoids
- (2019) Seri Jo et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- DrugBank 5.0: a major update to the DrugBank database for 2018
- (2017) David S Wishart et al. NUCLEIC ACIDS RESEARCH
- Pentagalloylglucose (PGG): A valuable phenolic compound with functional properties
- (2017) Cristian Torres-León et al. Journal of Functional Foods
- Therapeutic Potential of Epigallocatechin Gallate Nanodelivery Systems
- (2017) Andreia Granja et al. Biomed Research International
- Multiscale modeling of virus replication and spread
- (2016) Peter Kumberger et al. FEBS LETTERS
- SARS and MERS: recent insights into emerging coronaviruses
- (2016) Emmie de Wit et al. NATURE REVIEWS MICROBIOLOGY
- Green tea catechin, epigallocatechin-3-gallate (EGCG): Mechanisms, perspectives and clinical applications
- (2011) Brahma N. Singh et al. BIOCHEMICAL PHARMACOLOGY
- Anti-Cancer, Anti-Diabetic and Other Pharmacologic and Biological Activities of Penta-Galloyl-Glucose
- (2009) Jinhui Zhang et al. PHARMACEUTICAL RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More